Recently, increasing studies have revealed that MYOF is overexpressed in many kinds of human cancers, including pancreas cancer [21, 22], ovarian carcinoma [23], prostate cancer [24], breast cancer and renal cell cancer [25, 26], indicating that this protein may have important roles in tumorigenesis and malignant progression. Here, MYOF is linked to breast cancer.